La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Nukkleus a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Nukkleus..

Nukkleus (NASDAQ:NUKK) Azioni, Catena delle Opzioni

Nukkleus

Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically, the majority of its revenue is generated from the United Kingdom and the rest from the United States and Malta.

Nukkleus Inc

WIIM

APYX

Apyx Medical shares are trading lower after the company cut its FY24 and FY25 revenue guidance.

VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>, Euronext Amsterdam: VEON))), a global digital operator, is pleased to announce that a VEON delegation led by VEON Chairman and Founder Augie Fabela, VEON Group CEO Kaan Terzioglu and Jazz CEO Aamir Ibrahim visited Prime Minister of Pakistan Shehbaz Sharif today in Islamabad, to discuss the advancement of the country's digital landscape.
The Prime Minister commended Jazz's role in driving digital transformation and fostering economic empowerment through technology. During the meeting, the VEON delegation provided a comprehensive overview of VEON's substantial investments in Pakistan's digital infrastructure through Jazz and Mobilink Bank, serving more than 70 million mobile users, more than 63 million monthly active users (MAUs) across its digital services such as JazzCash, Tamasha, Simosa, and thousands of enterprise clients from small and medium businesses to the country's largest national and multinational conglomerates, supporting the digitalization of Pakistan's economy.
The delegation also met with Finance Minister Muhammad Aurangzeb; Minister of State for IT &amp; Telecommunications Shaza Fatima Khawaja; Jameel Ahmed, the Governor of the State Bank of Pakistan; Pakistan Telecommunications Authority Chairman Major General (R) Hafeez-Ur-Rehman.

News

Global

VEON

VEON Group Reaffirms Commitment To Strengthen Pakistan's Digital Infrastructure In Meeting With Prime Minister Shehbaz Sharif

Piper Sandler analyst Anna Andreeva maintains Warby Parker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRBY#NYSE">WRBY</a>) with a Overweight and raises the price target from $18 to $22.

Price Target

Analyst Ratings

WRBY

Piper Sandler Maintains Overweight on Warby Parker, Raises Price Target to $22

Benchmark analyst Daniel Kurnos maintains Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) with a Buy and raises the price target from $180 to $200.

EXPE

Benchmark Maintains Buy on Expedia Group, Raises Price Target to $200

PBYI

Puma Biotechnology shares are trading higher after the company reported better-than-expected Q3 financial results and raised the lower end of its Q24 revenue guidance.

Piper Sandler analyst Patrick Moley maintains Marex Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRX#NASDAQ">MRX</a>) with a Overweight and raises the price target from $30 to $32.

Piper Sandler Maintains Overweight on Marex Group, Raises Price Target to $32

On Friday, Amneal Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) reported third-quarter adjusted EPS of $0.16, down from $0.19 a year ago, beating the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $0.14</a>.
The company reported sales of $702.47 million, up 13% year-over-year, beating the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41838696/amneal-reports-third-quarter-2024-financial-results" rel="noreferrer noopener">consensus of $696.80 million</a>.
Generic net revenue increased by 9% to $427.35 million, driven by the strong performance of new product launches and biosimilars.
Specialty net revenue increased 19% to $115.64 million, driven by promoted products in neurology and endocrinology, including the recent launches of CREXONT&nbsp;and ONGENTYS&nbsp;for Parkinson&#8217;s disease.
AvKARE&#8217;s net revenue increased by 21% to $159.49 million, driven by growth across its distribution and government-label sales channels.
Adjusted EBITDA in the third quarter of 2024 was $158 million, an increase of 2% compared to the third quarter of 2023, reflective of strong revenue performance and higher gross margins, partially offset by a $20 million research and development milestone payment associated with the company&#8217;s exclusive license of Omalizumab during the third quarter of 2024.
&#8220;Q3 was an excellent quarter where we continued to drive strong financial results across our diversified business and we announced three strategic actions to solidify our long-term growth:
<ol>
<li>We launched CREXONT for the treatment of Parkinson&#8217;s disease.</li>
<li>We announced our collaboration with Metsera, Inc. to leverage Amneal&#8217;s expertise and supply next-generation medicines for obesity and metabolic diseases.</li>
<li>We expanded our deep pipeline by in-licensing a new high-value biosimilar,&#8221; said Chirag and Chintu Patel, Co-CEOs.</li>
</ol>
Guidance: Amneal has reaffirmed its 2024 revenue guidance of $2.7 billion—$2.8 billion and adjusted EPS of $0.57-$0.63, versus the consensus of $2.76 billion and $0.60, respectively.
The company expects 2024 adjusted EBITDA of $610 million—$630 million, operating cash flow&nbsp;of $280 million—$320 million and capital expenditures of $60 million—$70 million.
Price Action: At last check on Friday, AMRX stock down up 4.88% to $8.19 during the premarket session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/forex/24/11/41839609/asia-markets-mixed-europe-crude-oil-gold-and-dollar-cool-off-global-markets-today-while-us-slept" target="_blank" rel="noreferrer noopener">Asia Markets Mixed, Europe, Crude Oil, Gold, And Dollar Cool Off &#8211; Global Markets Today While US Slept</a></li>
</ul>

Earnings

Guidance

Health Care

Movers

General

AMRX

Generic Drug-Focused Amneal Beats Q3 Expectations, Reaffirms Annual Forecasts

Clover Leaf Capital Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLOE#OTC">CLOE</a>) (the "Company" or "Clover Leaf"), announced today that Clover Leaf and Kustom Entertainment, Inc. ("Kustom Entertainment") have mutually agreed to terminate their previously announced Agreement and Plan of Merger (the "Merger Agreement"), effective as of&nbsp;November 7, 2024&nbsp;by entering into a mutual termination and release agreement (the "Termination and Release Agreement") among Clover Leaf,&nbsp;CL Merger Sub, Inc., Yntegra Capital Investments LLC, Kustom Entertainment and Digital Ally, Inc.&nbsp;
The Merger Agreement was dated as of June 1, 2023, as amended on June 24, 2024 and on September 3, 2024. The Termination and Release Agreement terminates the Merger Agreement, which will be described in a Current Report on Form 8-K to be filed by Clover Leaf.
In view of the termination of the Merger Agreement, Clover Leaf also announced its decision to cancel its special meeting originally scheduled for November 8, 2024 and the withdrawal from consideration by the stockholders of the Company the proposals set forth in the Company's definitive proxy statement, as amended, filed with the Securities and Exchange Commission (the "SEC") on July 31, 2024 (the "Definitive Proxy Statement").
As a result of the termination of the Merger Agreement, the Company's Board of Directors has determined to liquidate the Company and expects that it will redeem all of its outstanding shares of Class A common stock sold as part of the units in the Company's initial public offering. The Company expects to announce additional information on such redemption in the coming days.

Contracts

CLOE

Clover Leaf Capital Corp. Announces Termination Of Merger Agreement With Kustom Entertainment, Inc., Cancellation Of Special Meeting Originally Scheduled For November 8, 2024 And Its Intention To Liquidate And Redeem All Of Its Outstanding Shares Of Class A Common Stock Sold As Part Of The Units In The Company's Initial Public Offering

ULBI

Ultralife shares are trading lower after the company reported worse-than-expected Q3 financial results.

STKS

The One Group Hospitality shares are trading lower after the company reported worse-than-expected Q3 financial results.

Piper Sandler analyst Charles Neivert maintains Dow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) with a Overweight and lowers the price target from $62 to $60.

Piper Sandler Maintains Overweight on Dow, Lowers Price Target to $60

Citigroup analyst Peter Christiansen upgrades Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) from Neutral to Buy and raises the price target from $56 to $87.

Upgrades

UPST

Citigroup Upgrades Upstart Hldgs to Buy, Raises Price Target to $87

TNYA

Tenaya Therapeutics shares are trading higher after the company reported better-than-expected Q3 EPS results. Chardan Capital maintained a Buy rating on the stock.

Envoy Medical&#xAE;, Inc. ("Envoy Medical") (NASDAQ: "COCH"), a hearing health company focused on fully implanted hearing systems, today announces that the European Patent Office has granted the Company Patent No. 3858425, titled," Implantable Modular Cochlear Implant System with Communication System and Network."
The patent relates to a modular cochlear implant system configured to receive input signals from an implantable source and a wireless receiving device and output a stimulation signal based on the received input signals and a programmable mixing ratio representative of the relative contributions of the input signals to the stimulation signal.&nbsp;

Envoy Medical, Inc. - Class A Common Stock

COCH

Envoy Medical Receives European Patent No. 3858425, Titled, "Implantable Modular Cochlear Implant System With Communication System And Network"

Piper Sandler analyst Charles Neivert maintains CF Industries Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>) with a Underweight and raises the price target from $77 to $79.

Piper Sandler Maintains Underweight on CF Industries Holdings, Raises Price Target to $79

CTMX

CytomX Therapeutics shares are trading higher after the company reported better-than-expected Q3 financial results.

AMC Networks Inc&nbsp;(NASDAQ: AMCX)&nbsp;reported a fiscal third-quarter 2024 revenue decline of 5.9% year over year to $599.6 million, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/g41842840/amc-networks-inc-reports-third-quarter-2024-results" rel="noreferrer noopener">analyst consensus estimate of $587.6 million</a>.
The American entertainment company's adjusted EPS of 91 cents fell 50.8% yearly, beating the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate of 62 cents</a>. 
Domestic Operations:&nbsp;Affiliate revenue decreased 13% to $164 million due to&nbsp;basic&nbsp;subscriber declines.
Also Read: <a href="https://www.benzinga.com/news/earnings/24/11/41780782/why-is-iron-mountain-stock-plunging-on-wednesday" target="_blank" rel="noreferrer noopener">Why Is Iron Mountain Stock Plunging On Wednesday?</a>
<ul>
<li>Advertising revenues decreased 10% Y/Y to $133 million due to anticipated linear ratings declines and a challenging ad market.&nbsp;</li>
<li>Content licensing revenues increased 31% to $81 million due to the availability of deliveries.</li>
<li>Despite these setbacks, AMC Networks reported that streaming subscribers increased by 5% to 11.8 million compared to 11.1 million subscribers as of Sept. 30, 2023.</li>
<li>Streaming revenues of $152 million increased by 7%, primarily driven by year-over-year streaming subscriber growth and price increases.</li>
<li>The consolidated adjusted operating income decreased 19% to $150 million, with free cash flow at $53.94 million.</li>
</ul>
CEO Kristin Dolan emphasized the company's focus on critical strategic pillars: programming, partnerships, and profitability. 
Dolan noted significant progress in all three areas during the quarter. 
Year-to-date, the company has generated $293 million in free cash flow, moving steadily toward its goal of around $500 million in cumulative free cash over two years. 
Dolan also highlighted new and expanded partnerships with significant players like Charter Communications, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>), Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), and Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), which are helping drive the company forward while delivering unique, high-quality programming across a growing range of platforms.
Price Action: AMC Networks stock is up 4.79% to $8.75 premarket at the last check on Friday. It plunged close to 57% year-to-date as the company&#8217;s adjusted EPS missed the consensus in the last 3 quarters.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41778593/trimble-beats-q3-expectations-boasts-record-revenue-as-ceo-outlines-focused-growth-strategy" target="_blank" rel="noreferrer noopener">Trimble Beats Q3 Expectations, Boasts Record Revenue As CEO Outlines Focused Growth Strategy</a></li>
</ul>

AMCX

AMZN

CHTR

NFLX

AMC Networks Q3 Earnings: Streaming Subscriber Growth Shines Amid Ad Revenue Dip Bolstered By Netflix, Amazon Partnerships

Piper Sandler analyst Michael Lavery maintains Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) with a Neutral and raises the price target from $165 to $168.

Piper Sandler Maintains Neutral on Hershey, Raises Price Target to $168

Benchmark analyst Mike Hickey maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Sell and raises the price target from $10 to $15.

Benchmark Maintains Sell on Unity Software, Raises Price Target to $15

BMRA

Biomerica shares are trading higher after the company was granted an additional 180 days to meet Nasdaq listing compliance requirements

Nukkleus (NUKK) just unveiled an update. Nukkleus Inc. has secured a financial boost by issuing a $312,500 Senior Unsecured Promissory Note to X Gr...

Nukkleus Announces Strategic Financing and Governance Enhancements

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!



Moving stocks this morning are earnings reports, insider buying, offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Volcon (NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) stock is rocketing more than 78% alongside heavy pre-market trading.</li>



<li>Senti Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/snti-stock-quote/">SNTI</a>) shares are soaring over 47% with strong early morning trading.</li>



<li>GlycoMimetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/glyc-stock-quote/">GLYC</a>) stock is surging more than 39% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318411360&amp;type=PDF&amp;symbol=GLYC&amp;cdn=8f7645b9da4ce31c36360d7737c007dc&amp;companyName=GlycoMimetics+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-24">alongside insider buying</a>.</li>



<li>Anew Medical (OTCMKTS:<a href="https://investorplace.com/stock-quotes/leas-stock-quote/">LEAS</a>) shares are gaining over 38% without any clear news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are increasing more than 24% with strong pre-market trading.</li>



<li>Regis (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgs-stock-quote/">RGS</a>) stock is rising over 21% after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318412499&amp;type=PDF&amp;symbol=RGS&amp;cdn=4f01bbb678bba4ddafaac79f77ec0544&amp;companyName=Regis+Corporation&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-25">senior secured credit facility</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares are heading close to 20% higher with heavy pre-market trading today.</li>



<li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is jumping more than 17% <a href="https://www.nasdaq.com/press-release/kaival-brands-announces-closing-60-million-public-offering-2024-06-24">after closing a public offering</a>.</li>



<li>BioXcel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/btai-stock-quote/">BTAI</a>) shares are climbing over 13% on <a href="https://www.nasdaq.com/press-release/bioxcel-therapeutics-announces-positive-topline-results-post-marketing-requirement">topline results from a study</a>.</li>



<li>Captivision (NASDAQ:<a href="https://investorplace.com/stock-quotes/capt-stock-quote/">CAPT</a>) stock is up more than 12% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Faraday Future (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/">FFIE</a>) stock is plummeting over 25% on plans for a <a href="https://finance.yahoo.com/news/faraday-future-announces-plans-regaining-215900667.html">reverse stock split</a>.</li>



<li>Concord Medical Services (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/">CCM</a>) shares are diving more than 22% after a massive rally yesterday.</li>



<li>Beyond Air (NASDAQ:<a href="https://investorplace.com/stock-quotes/xair-stock-quote/">XAIR</a>) stock is tumbling over 19% on <a href="https://finance.yahoo.com/news/beyond-air-inc-xair-reports-212503389.html">lackluster Q4 earnings</a>.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) shares are retreating more than 19% <a href="https://investorplace.com/2024/06/why-is-microalgo-mlgo-stock-up-113-today/">after rallying yesterday</a>.</li>



<li>SolarEdge Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sedg-stock-quote/">SEDG</a>) stock is taking an over 16% beating on a <a href="https://www.nasdaq.com/press-release/solaredge-technologies-inc-announces-proposed-private-offering-300-million">$300 million private offering</a>.</li>



<li>IGC Pharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/igc-stock-quote/">IGC</a>) shares are dropping more than 16% on its <a href="https://www.nasdaq.com/press-release/igc-reports-financial-results-fiscal-year-ended-march-31-2024-2024-06-24">latest earnings report</a>.</li>



<li>Oragenics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/">OGEN</a>) stock is falling over 15% on a <a href="https://www.stocktitan.net/news/OGEN/oragenics-inc-announces-proposed-public-688vwqnwez4o.html">proposed public offering</a>.</li>



<li>DermTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/">DMTK</a>) shares are decreasing nearly 12% after a <a href="https://www.nasdaq.com/press-release/dermtech-files-voluntary-chapter-11-protection-2024-06-18">recent bankruptcy filing</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) stock is slipping more than 11% with recent weakness.</li>



<li>36KR (NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/">KRKR</a>) shares close out our pre-market stock movers down over 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have the biggest pre-market stock movers that traders are going to want to start the week with on Monday morning!



Moving stocks this morning are Roaring Kitty news, a company filing for bankruptcy and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) stock is rocketing 88% alongside heavy pre-market trading.</li>



<li>Golden Heaven (NASDAQ:<a href="https://investorplace.com/stock-quotes/gdhg-stock-quote/">GDHG</a>) shares are soaring close to 43% with strong early morning trading.</li>



<li>Chewy (NYSE:<a href="https://investorplace.com/stock-quotes/chwy-stock-quote/">CHWY</a>) stock is surging almost 19% as Roaring Kitty <a href="https://www.cnbc.com/2024/07/01/chewy-shares-rally-20percent-after-sec-filing-reveals-roaring-kitty-keith-gill-has-6point6percent-stake.html">takes a stake in the company</a>.</li>



<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) shares are increasing more than 16% on a <a href="https://www.nasdaq.com/press-release/mesoblast-file-biologics-license-application-ryoncilr-fda-approval-next-week-2024-07">new biologics license application</a>.</li>



<li>Barfresh Food (NASDAQ:<a href="https://investorplace.com/stock-quotes/brfh-stock-quote/">BRFH</a>) stock is rising over 16% despite a lack of news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are gaining nearly 15% with strong pre-market trading.</li>



<li>Incannex Healthcare (NASDAQ:<a href="https://investorplace.com/stock-quotes/ixhl-stock-quote/">IXHL</a>) stock is climbing more than 12% without any clear news today.</li>



<li>Tempus AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/tem-stock-quote/">TEM</a>) shares are getting an over 13% boost <a href="https://www.tradingview.com/news/reuters.com,2024:newsml_L1N3IQ0UH:0-tempus-ai-rallies-in-three-day-recovery-still-below-ipo-price/">with a recent rally</a> after its initial public offering (<a href="https://investorplace.com/stock-quotes/ipo-stock-quote/">IPO</a>) last month.</li>



<li>Lion Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/lghl-stock-quote/">LGHL</a>) stock is jumping more than 13% with heavy early morning trading today.</li>



<li>Hollysys Automation Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/holi-stock-quote/">HOLI</a>) shares are up over 13% without any obvious news this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Delta Apparel (NYSEMKT:<a href="https://investorplace.com/stock-quotes/dla-stock-quote/">DLA</a>) stock is plummeting more than 34% despite no clear news this morning.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are diving over 20% after <a href="https://fortune.com/2024/06/29/redbox-dvd-kiosks-chicken-soup-for-the-soul-chapter-11-bankruptcy-filing/">filing for Chapter 11 bankruptcy</a>.</li>



<li>African Agriculture (NASDAQ:<a href="https://investorplace.com/stock-quotes/aagr-stock-quote/">AAGR</a>) stock is tumbling more than 14% alongside recent volatility.</li>



<li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssep-stock-quote/">CSSEP</a>) shares are taking an over 14% beating with the bankruptcy filing.</li>



<li>Chicken Soup for the Soul Entertainment, Inc. &ndash; 9.50% Notes due 2025 (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssen-stock-quote/">CSSEN</a>) are sliding more than 12% alongside the bankruptcy news.</li>



<li>Wang &amp; Lee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wlgs-stock-quote/">WLGS</a>) stock is falling 12% after a Friday rally.</li>



<li>Lakeside (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSH#NASDAQ">LSH</a>) shares are dropping over 10% this morning.</li>



<li>Li-Cycle (NYSE:<a href="https://investorplace.com/stock-quotes/licy-stock-quote/">LICY</a>) stock is decreasing more than 10% on an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425152&amp;type=PDF&amp;symbol=LICY&amp;cdn=adb9d0bf10804596acf67ff3f07cb9bd&amp;companyName=Li-Cycle+Holdings+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">at-market sales agreement</a>.</li>



<li>AgriForce Growing Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/agri-stock-quote/">AGRI</a>) shares are slipping over 10% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318425454&amp;type=PDF&amp;symbol=AGRI&amp;cdn=5153a3d8a3670dcb6c5185b3625a84cd&amp;companyName=AgriFORCE++Growing+Systems+Ltd.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-28">a delisting notice</a>.</li>



<li>Assure (NASDAQ:<a href="https://investorplace.com/stock-quotes/ionm-stock-quote/">IONM</a>) stock closes out our pre-market stock movers down more than 10%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-1st/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning as we break down all of the biggest news sending shares higher and lower on Tuesday!



Moving stocks this morning are a bankruptcy filing, earnings reports, new deals and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chicken Soup for the Soul Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssep-stock-quote/">CSSEP</a>) stock is rocketing more than 222% after <a href="https://investorplace.com/2024/07/why-is-chicken-soup-for-the-soul-entertainment-csse-stock-down-29-today/">falling yesterday on a bankruptcy filing</a>. </li>



<li>Chicken Soup for the Soul Entertainment, Inc. &ndash; 9.50% Notes due 2025 (NASDAQ:<a href="https://investorplace.com/stock-quotes/cssen-stock-quote/">CSSEN</a>) are soaring close to 82% after yesterday&rsquo;s drop.</li>



<li>Roadzen (NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/">RDZN</a>) shares are surging over 60% alongside its <a href="https://www.stocktitan.net/news/RDZN/roadzen-reports-record-revenue-growth-in-its-first-fiscal-year-as-a-47jyl3yay9h1.html">first public year-end earnings</a>.</li>



<li>IMAC (NASDAQ:<a href="https://investorplace.com/stock-quotes/back-stock-quote/">BACK</a>) stock is gaining more than 37% without any clear news this morning.</li>



<li>Versus Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/vs-stock-quote/">VS</a>) shares are rising over 31% after <a href="https://www.marketwatch.com/story/versus-systems-shares-climb-on-interim-ceo-appointment-business-review-589cd51b">naming an interim CEO</a>.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) stock is increasing 30% despite a lack of news this morning.</li>



<li>Chicken Soup for the Soul (NASDAQ:<a href="https://investorplace.com/stock-quotes/csse-stock-quote/">CSSE</a>) shares are climbing more than 19% with its bankruptcy filing.</li>



<li>Ocean Power Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/optt-stock-quote/">OPTT</a>) stock is heading over 16% higher alongside heavy pre-market trading.</li>



<li>US Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/useg-stock-quote/">USEG</a>) shares are jumping more than 14% <a href="https://www.nasdaq.com/press-release/us-energy-corp-announces-transformative-acquisition-targeting-helium-production-2024">on a new acquisition deal</a>.</li>



<li>VS Media (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsme-stock-quote/">VSME</a>) stock is up over 14% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) stock is plummeting nearly 35% despite a lack of news this morning.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) shares are diving almost 15% without any apparent news today.</li>



<li>Applied DNA Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/apdn-stock-quote/">APDN</a>) stock is tumbling close to 12% without any news to note.</li>



<li>Senti Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/snti-stock-quote/">SNTI</a>) shares are taking a more than 11% beating <a href="https://ca.investing.com/news/company-news/senti-biosciences-awarded-8-million-for-cancer-trial-93CH-3480501">after a cancer funding rally yesterday</a>.</li>



<li>Datasea (NASDAQ:<a href="https://investorplace.com/stock-quotes/dtss-stock-quote/">DTSS</a>) stock is sliding close to 11% after <a href="https://www.marketwatch.com/story/datasea-shares-up-20-on-three-sales-agreements-for-china-units-de49a130">rallying yesterday on sales agreements</a>.</li>



<li>Presto Automation (NASDAQ:<a href="https://investorplace.com/stock-quotes/prst-stock-quote/">PRST</a>) shares are falling over 10% despite a lack of news this morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is decreasing more than 10% without any news to report.</li>



<li>Hudson Pacific Properties (NYSE:<a href="https://investorplace.com/stock-quotes/hpp-stock-quote/">HPP</a>) shares are dropping over 10% despite a lack of relevant news today.</li>



<li>Vintage Wine Estates (NASDAQ:<a href="https://investorplace.com/stock-quotes/vwe-stock-quote/">VWE</a>) stock is slipping more than 10% this morning.</li>



<li>Akso Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/ahg-stock-quote/">AHG</a>) shares close out our pre-market stock movers down over 10% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!



Moving stocks this morning are earnings reports, a settlement agreement, the pricing of a public offering and more.



Let&rsquo;s get into that below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is rocketing close to 254% alongside heavy pre-market trading.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) shares are soaring more than 122% with strong early morning trading.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is surging nearly 78% with heavy early morning trading today.</li>



<li>Frequency Electronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/feim-stock-quote/">FEIM</a>) shares are rising almost 33% alongside its <a href="https://www.marketwatch.com/story/frequency-electronics-shares-climb-on-higher-4q-earnings-a32189da">Q4 earnings report</a>.</li>



<li>Mammoth Energy Services (NASDAQ:<a href="https://investorplace.com/stock-quotes/tusk-stock-quote/">TUSK</a>) stock is heading over 29% higher after <a href="https://www.nasdaq.com/press-release/cobra-acquisitions-llc-announces-settlement-agreement-prepa-2024-07-22">announcing a settlement agreement</a>.</li>



<li>ENGlobal (NASDAQ:<a href="https://investorplace.com/stock-quotes/eng-stock-quote/">ENG</a>) shares are gaining more than 22% without any clear news.</li>



<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is jumping over 20% with no news to report.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are climbing more than 19% despite a lack of news on Tuesday.</li>



<li>SCYNEXIS (NASDAQ:<a href="https://investorplace.com/stock-quotes/scyx-stock-quote/">SCYX</a>) stock is getting an over 15% boost on a <a href="https://www.nasdaq.com/press-release/scynexis-receive-10-million-milestone-payment-gsk-triggered-delivery-completed-furi">$10 million milestone payment</a>.</li>



<li>Professional Diversity (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/">IPDN</a>) shares are up more than 13% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is crashing more than 59% after <a href="https://www.nasdaq.com/press-release/transcode-therapeutics-inc-announces-pricing-public-offering-2024-07-22">pricing a public offering</a>.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are plummeting close to 31% <a href="https://investorplace.com/2024/07/why-is-mira-pharmaceuticals-mira-stock-up-318-today/">after a massive rally yesterday</a>.</li>



<li>Brera (NASDAQ:<a href="https://investorplace.com/stock-quotes/brea-stock-quote/">BREA</a>) stock is diving nearly 25% with strong pre-market trading this morning.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) shares are tumbling over 22% <a href="https://www.benzinga.com/news/24/07/39892411/caremax-shares-are-up-by-more-than-200-what-you-need-to-know">after a rally yesterday</a>.</li>



<li>Nukkleus (NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/">NUKK</a>) stock is taking a more than 19% beating after a recent rally.</li>



<li>Castellum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ctm-stock-quote/">CTM</a>) shares are sliding over 19% <a href="https://investorplace.com/2024/07/why-is-castellum-ctm-stock-moving-today/">alongside volatility yesterday</a>.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) stock is falling almost 16% as shares <a href="https://investorplace.com/2024/07/why-is-exicure-xcur-stock-down-27-today/">continue to come off a recent rally</a>.</li>



<li>Quoin Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/qnrx-stock-quote/">QNRX</a>) shares are dropping more than 15% today.</li>



<li>Polaris (NYSE:<a href="https://investorplace.com/stock-quotes/pii-stock-quote/">PII</a>) stock is slipping over 15% after <a href="https://www.marketwatch.com/story/polaris-stock-tumbles-11-after-earnings-fall-far-short-of-consensus-and-company-cuts-full-year-outlook-c3299335">missing earnings estimates</a>.</li>



<li>Netcapital (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/">NCPL</a>) shares close out our pre-market stock movers down more than 14%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-july-23rd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

An update from Nukkleus (NUKK) is now available. Emil Assentato has stepped down as CEO and board member of Nukkleus Inc., with Jamie Khurshid taki...

Nukkleus Appoints Jamie Khurshid as New CEO

Nukkleus ( ($NUKK) ) just unveiled an announcement. In a significant corporate reshuffle, a company issued a note that will mature in September 202...

Nukkleus Announces Leadership Changes and Strategic Reorganization

Nukkleus to implement 1-for-8 reverse stock split

Nukkleus (NUKK) announced that it will effect a 1-for-8 reverse split of the issued shares of its common stock, effective on October 24, 2024. The ...

Nukkleus announces 1-for-8 reverse stock split

19:50 EDT Nukkleus (NUKK) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...

Nukkleus Inc trading halted, news pending

AAGR

AGRI

APDN

BACK

BREA

BRFH

BTAI

CAPT

CHWY

CMAX

CONN

CSSE

CSSEN

CSSEP

DMTK

DTSS

FEIM

FFIE

GDHG

GLYC

GNLN

HOLI

IONM

IPDN

IXHL

KAVL

KRKR

LEAS

LGHL

LICY

LPTV

MESO

MIRA

MLGO

NCPL

NMHI

NUKK

OGEN

OPTT

PRST

QNRX

RDZN

RNAZ

SCYX

SEDG

SNTI

SOAR

TUSK

USEG

VLCN

VSME

WHLR

WLGS

WRNT

XAIR

ZAPP

Fintech

Small Cap

Press Releases

Nukkleus Inc. Closes Merger with Brilliant Acquisition Corporation

Nukkleus Releases Updated Corporate Presentation: Lays Out Vision for Building Financial Infrastructure of the Future

Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management

Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa

Opinion

Thinking about buying stock in Petros Pharmaceuticals, Xpeng Inc, Nukkleus, Cellectar Biosciences, or bluebird bio?

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets

Goldman Sachs Acquires Stake in Fintech Trailblazer Nukkleus According to a Recent SEC Filing

Nukkleus Signs Term Sheet for Acquisition of Leading Cross Border Payments Firm Mercury Global

Thinking about buying stock in BigBear.ai, Nukkleus, Singularity Future Technology, Regulus Therapeutics, or ATRenew?

Nukkleus Announces Reverse Stock Split Shares Will Begin Trading on a Split-Adjusted Basis on October 24, 2024

Comments

Nukkleus

Nukkleus (NUKK) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO